Low-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings
Open Access
- 22 August 2026
- journal article
- case report
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (11) , 5520-5525
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomanpj Genomic Medicine, 2024
- New kids on the block: FOS and FOSB geneJournal of Clinical Pathology, 2023
- Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?Laboratory Investigation, 2022
- Epithelioid osteoblastoma with secondary aneurysmal bone cyst and FOS gene rearrangementSkeletal Radiology, 2021
- The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial OsteosarcomaHead and Neck Pathology, 2020
- Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastomaVirchows Archiv, 2019
- Primary aneurysmal bone cyst with a novel SPARC-USP6 translocation identified by next-generation sequencingCancer Genetics, 2018
- Factors Affecting Prognosis of Patients With Osteoblastoma of the Mobile Spine: A Long-Term Follow-up Study of 70 Patients in a Single CenterNeurosurgery, 2018
- Recurrent rearrangements of FOS and FOSB define osteoblastomaNature Communications, 2018
- Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimicsLaboratory Investigation, 2010